Iosis Remedies Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 07-07-2024
- Paid Up Capital ₹ 1.00 Cr
as on 07-07-2024
- Company Age 4 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.17 Cr
as on 07-07-2024
- Revenue 247.52%
(FY 2022)
- Profit 125.67%
(FY 2022)
- Ebitda 361.17%
(FY 2022)
- Net Worth 220.03%
(FY 2022)
- Total Assets 42.94%
(FY 2022)
About Iosis Remedies
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹3.17 Cr.
Rajesh Chandrabhan and Mahesh Kingrani serve as directors at the Company.
- CIN/LLPIN
U33110MH2020PTC340066
- Company No.
340066
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 May 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Iosis Remedies Private Limited offer?
Iosis Remedies Private Limited offers a wide range of products and services, including Sexual Wellness Products, Fertility Enhancer, Contraceptives, Pain Relief Drugs & Pharmaceuticals, Arthritic Drugs, Cardiovascular Drugs & Medication, Anticoagulant and Antiplatelet Drugs, TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Common Disease Medicines.
Who are the key members and board of directors at Iosis Remedies?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajesh Chandrabhan  | Director | 28-May-2020 | Current |
| Mahesh Kingrani | Director | 28-May-2020 | Current |
Financial Performance of Iosis Remedies.
Iosis Remedies Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 247.52% increase. The company also saw a substantial improvement in profitability, with a 125.67% increase in profit. The company's net worth Soared by an impressive increase of 220.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Iosis Remedies?
In 2022, Iosis Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Innovative Pharmaceuticals Private LimitedActive 4 years 5 monthsRajesh Chandrabhan and Mahesh Kingrani are mutual person
Ikon Remedies Private LimitedActive 22 years 2 monthsRajesh Chandrabhan and Mahesh Kingrani are mutual person
Oak Sterling Vista LlpActive 1 year 7 monthsRajesh Chandrabhan and Mahesh Kingrani are mutual person
- Searle Remedies LimitedActive 12 years 6 months
Rajesh Chandrabhan and Mahesh Kingrani are mutual person
- Hathway Wellness Private LimitedActive 4 years 8 months
Rajesh Chandrabhan and Mahesh Kingrani are mutual person
- Pure Organic Products Private LimitedActive 1 year 1 month
Rajesh Chandrabhan and Mahesh Kingrani are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 28 Oct 2020 | ₹3.17 Cr | Open |
How Many Employees Work at Iosis Remedies?
Iosis Remedies has a workforce of 30 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Iosis Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Iosis Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
